Substitute parameters of exercise-induced pulmonary hypertension and usefulness of low workload exercise stress echocardiography in mitral regurgitation.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
25 09 2022
Historique:
received: 11 06 2022
accepted: 07 09 2022
entrez: 26 9 2022
pubmed: 27 9 2022
medline: 28 9 2022
Statut: epublish

Résumé

In asymptomatic patients with mitral regurgitation (MR), data of exercise-induced pulmonary hypertension (EIPH) are limited, and feasibility of evaluating EIPH is not high. We aimed to investigate prognostic impact of EIPH and its substitute parameters. Exercise stress echocardiography (ESE) were performed in 123 consecutive patients with moderate to severe degenerative MR. The endpoint was a composite of death, hospitalization for heart failure, and worsening of symptoms. EIPH [tricuspid regurgitation peak gradient (TRPG) at peak workload ≥ 50 mmHg] was shown in 57 patients (46%). TRPG at low workload was independently associated with TRPG at peak workload (β = 0.67, p < 0.001). Early surgical intervention (within 6 months after ESE) was performed in 65 patients. Of the remaining 58 patients with the watchful waiting strategy, the event free survival was lower in patients with EIPH than in patients without EIPH (48.1 vs. 97.0% at 1-year, p < 0.001). TRPG at low workload ≥ 35.0 mmHg as well as EIPH were associated with poor prognosis in patients with the watchful waiting strategy. In conclusion, the importance of ESE and evaluating EIPH in patients with MR was re-acknowledged. TRPG at peak workload can be predicted by TRPG at low workload, and TRPG at low workload may be useful in real-world clinical settings.

Identifiants

pubmed: 36155621
doi: 10.1038/s41598-022-19987-8
pii: 10.1038/s41598-022-19987-8
pmc: PMC9510128
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

15977

Informations de copyright

© 2022. The Author(s).

Références

Circulation. 2012 Aug 14;126(7):851-9
pubmed: 22832784
Circulation. 2021 Feb 2;143(5):e72-e227
pubmed: 33332150
Eur J Echocardiogr. 2011 Mar;12(3):167-205
pubmed: 21385887
Circulation. 2010 Jul 6;122(1):33-41
pubmed: 20566950
J Am Soc Echocardiogr. 2011 Sep;24(9):1004-12
pubmed: 21592726
J Am Soc Echocardiogr. 2017 Apr;30(4):303-371
pubmed: 28314623
Eur Heart J. 2022 Feb 12;43(7):561-632
pubmed: 34453165
Clin Cardiol. 2015 Oct;38(10):621-8
pubmed: 26442458
JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt B):1253-1264
pubmed: 28017395
Circulation. 2000 Nov 7;102(19):2378-84
pubmed: 11067792
J Am Soc Echocardiogr. 2008 Dec;21(12):1331-6
pubmed: 19041577
Prog Cardiovasc Dis. 2017 Nov - Dec;60(3):342-350
pubmed: 29128571
J Card Fail. 2008 Jun;14(5):379-87
pubmed: 18514929
Respirology. 2021 Mar;26(3):264-272
pubmed: 33118293
Heart. 2007 Apr;93(4):476-82
pubmed: 17005715
Eur Heart J Cardiovasc Imaging. 2012 Nov;13(11):922-30
pubmed: 22504944
J Am Coll Cardiol. 2010 Jul 20;56(4):300-9
pubmed: 20633822
J Am Coll Cardiol. 1994 Feb;23(2):443-51
pubmed: 8294699
Circ J. 2020 Oct 23;84(11):2037-2119
pubmed: 32921646
Circ Cardiovasc Imaging. 2013 Mar 1;6(2):167-76
pubmed: 23357242
J Am Coll Cardiol. 1989 Aug;14(2):319-22
pubmed: 2754121
Eur Heart J Cardiovasc Imaging. 2016 Nov;17(11):1191-1229
pubmed: 27880640
Pulm Circ. 2020 Oct 2;10(3):2045894020950187
pubmed: 33062259
Eur Heart J. 2014 Jun 21;35(24):1608-16
pubmed: 24014387
J Am Coll Cardiol. 2018 Feb 13;71(6):700-701
pubmed: 29420967
J Echocardiogr. 2018 Sep;16(3):105-129
pubmed: 29876799
J Am Coll Cardiol. 1995 Mar 1;25(3):703-9
pubmed: 7860917
J Cardiol. 2015 Sep;66(3):246-52
pubmed: 25533424
Eur Heart J Cardiovasc Imaging. 2019 Sep 1;20(9):1027-1034
pubmed: 30824900

Auteurs

Masashi Amano (M)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-shimmachi, Suita, Osaka, 564-8565, Japan.

Shoko Nakagawa (S)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-shimmachi, Suita, Osaka, 564-8565, Japan.

Kenji Moriuchi (K)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-shimmachi, Suita, Osaka, 564-8565, Japan.

Hitomi Nishimura (H)

Department of Clinical Laboratory, National Cerebral and Cardiovascular Center, Suita, Japan.

Yurie Tamai (Y)

Department of Clinical Laboratory, National Cerebral and Cardiovascular Center, Suita, Japan.

Ayaka Mizumoto (A)

Department of Clinical Laboratory, National Cerebral and Cardiovascular Center, Suita, Japan.

Yoshiki Yanagi (Y)

Department of Clinical Laboratory, National Cerebral and Cardiovascular Center, Suita, Japan.

Rika Yonezawa (R)

Department of Clinical Laboratory, National Cerebral and Cardiovascular Center, Suita, Japan.

Yutaka Demura (Y)

Department of Clinical Laboratory, National Cerebral and Cardiovascular Center, Suita, Japan.

Yoshito Jo (Y)

Department of Clinical Laboratory, National Cerebral and Cardiovascular Center, Suita, Japan.

Yuki Irie (Y)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-shimmachi, Suita, Osaka, 564-8565, Japan.

Atsushi Okada (A)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-shimmachi, Suita, Osaka, 564-8565, Japan.

Takeshi Kitai (T)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-shimmachi, Suita, Osaka, 564-8565, Japan.

Makoto Amaki (M)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-shimmachi, Suita, Osaka, 564-8565, Japan.

Hideaki Kanzaki (H)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-shimmachi, Suita, Osaka, 564-8565, Japan.

Kengo Kusano (K)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-shimmachi, Suita, Osaka, 564-8565, Japan.

Teruo Noguchi (T)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-shimmachi, Suita, Osaka, 564-8565, Japan.

Kunihiro Nishimura (K)

Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Osaka, Japan.

Chisato Izumi (C)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-shimmachi, Suita, Osaka, 564-8565, Japan. izumi-ch@ncvc.go.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH